Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

AAN to award 2013 Michael S. Pessin Stroke Leadership Prize to Amytis Towfighi

The American Academy of Neurology is awarding the 2013 Michael S. Pessin Stroke Leadership Prize to Amytis Towfighi, MD, with the University of Southern California and Rancho Los Amigos National Rehabilitation Center for her research in post-stroke preventive care.

2 Mar 2013

Influenza vaccine linked to narcolepsy in children in England

Researchers have found an increased risk for narcolepsy in children who received the swine flu vaccination in England.

1 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

Researchers develop new genetically altered mice that model earliest stages of Alzheimer's

Researchers at the University of Florida and The Johns Hopkins University have developed a line of genetically altered mice that model the earliest stages of Alzheimer's disease. This model may help scientists identify new therapies to provide relief to patients who are beginning to experience symptoms.

1 Mar 2013

Brown University develops new implantable and rechargeable wireless brain sensor

A team of neuroengineers based at Brown University has developed a fully implantable and rechargeable wireless brain sensor capable of relaying real-time broadband signals from up to 100 neurons in freely moving subjects.

28 Feb 2013

Researchers bring hope for patients with aphasia

Two groups of researchers have presented preliminary results of studies aiming to help in the treatment of aphasia at the conference of the American Association for the Advancement of Science in Boston, Massachusetts, USA, this month.

28 Feb 2013

Einstein researchers to investigate consequences of soccer heading on the brain

Sports-related concussion is an increasingly recognized public health problem. At least 1.6 million sports- and recreation-related traumatic brain injuries occur in the United States annually. While the primary focus has been on football, soccer has come under greater scrutiny.

28 Feb 2013

Syphilis in pregnancy widespread but preventable

Syphilis is still a widespread problem among pregnant women worldwide, despite tests and treatment being inexpensive and readily available, show study findings.

27 Feb 2013

CellAegis Devices to use autoRIC Device for Chronic Remote Ischemic Conditioning

CellAegis Devices, Inc., announced today that it has received an Investigational Testing Approval from Health Canada that allows the initiation of clinical testing in Canada of the Company's autoRIC Device for Chronic Remote Ischemic Conditioning (CRIC).

27 Feb 2013

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

26 Feb 2013

‘Traffic light’ guide for pediatric bacterial infection needs refining

Study results suggest that a “traffic light” system for categorizing the severity of infections in children fails to detect a substantial number of serious bacterial infections, particularly urinary tract infections.

26 Feb 2013

Ill health more likely to be responsible for retirement in regional areas than in cities

Men and women of working age, living in regional areas are more likely to be fully retired because of ill health than their city counterparts, University of Sydney research shows.

26 Feb 2013

Henry Ford Hospital scientists to research into hypertension and tissue and organ damage

A senior staff scientist and his team at Henry Ford Hospital have been awarded a five-year, $12.4 million grant by the National Institutes of Health for their research into the damaging effects of high blood pressure on various organs in the body.

26 Feb 2013

BIOTRONIK receives FDA approval for Lumax 740 DX System

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the Food and Drug Administration (FDA) has granted final approval for the BIOTRONIK Lumax 740 DX System.

26 Feb 2013

LabCorp introduces GeneSeq: Carido for familial cardiac disease

Laboratory Corporation of America Holdings today announced it has launched its clinical next generation sequencing assay, GeneSeq: Cardio for genetic causes of familial cardiac disease.

26 Feb 2013

WOEST supports clopidogrel only in PCI patients on anticoagulation

Publication of the WOEST trial results reaffirm the study’s major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy.

25 Feb 2013

CHADS scores possibilities extend beyond atrial fibrillation

The CHADS-based risk scores can predict long-term vascular outcomes and mortality in patients with stroke who do not have atrial fibrillation, research suggests.

25 Feb 2013

Mechanisms of HPV-associated tumor spread under scrutiny

In patients with human papillomavirus-associated tonsillar carcinoma, second tumors in the contralateral tonsil are typically caused by the same viral variant, a case series indicates.

25 Feb 2013

Heightened stroke risk for patients with sleep apnea and atrial fibrillation

Atrial fibrillation may play an intermediary role in the relationship between obstructive sleep apnea and stroke, research findings suggest.

25 Feb 2013

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

25 Feb 2013